Efficacy and Safety of Simeprevir or Daclatasvir in Combination With Sofosbuvir for the Treatment of Hepatitis C Genotype 4 Infection. [electronic resource]
Producer: 20190726Description: 452-457 p. digitalISSN:- 1539-2031
- Adult
- Antiviral Agents -- administration & dosage
- Carbamates
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Imidazoles -- administration & dosage
- Liver Cirrhosis -- drug therapy
- Male
- Middle Aged
- Prospective Studies
- Pyrrolidines
- RNA, Viral -- blood
- Ribavirin -- administration & dosage
- Simeprevir -- administration & dosage
- Sofosbuvir -- administration & dosage
- Sustained Virologic Response
- Treatment Outcome
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.